testolactone has been researched along with Fibrous Dysplasia of Bone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hauffa, BP; Havers, W; Stolecke, H | 1 |
Barnes, K; Cutler, GB; Dwyer, A; Feuillan, PP; Foster, CM; Hench, KD; Loriaux, DL; Malley, JD; Pescovitz, OH; Shawker, T | 1 |
Comite, F; Cutler, GB; Feuillan, P; Foster, CM; Loriaux, DL; Pescovitz, OH; Shawker, T | 1 |
3 other study(ies) available for testolactone and Fibrous Dysplasia of Bone
Article | Year |
---|---|
Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome.
Topics: Androgen Antagonists; Body Height; Bone Development; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follow-Up Studies; Humans; Infant; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Cysts; Ovarian Function Tests; Spironolactone; Testolactone | 1987 |
Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Topics: Aromatase Inhibitors; Bone Development; Child, Preschool; Estradiol; Estrone; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Growth; Humans; Infant; Luteinizing Hormone; Menstruation; Ovary; Puberty, Precocious; Sexual Maturation; Testolactone | 1986 |
Testolactone treatment of precocious puberty in McCune-Albright syndrome.
Topics: Androstenedione; Child, Preschool; Endocrine System Diseases; Estradiol; Estrone; Female; Fibrous Dysplasia of Bone; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Puberty, Precocious; Syndrome; Testolactone; Testosterone; Triptorelin Pamoate | 1985 |